Coherence Neuro Raises $10 Million to Launch Closed-Loop Neuro System for Cancer Treatment

Coherence Neuro, a medical technology company working at the intersection of neurotechnology, neurobiology, and machine learning to improve the quality and length of life for people with cancer, led by Ben Woodington, Elise Jenkins, José Lepe, and Jason Miranda, has secured a $10 million seed round led by Topology Ventures and Artesian (Alternative Investments), with participation from Blackbird, Possible Ventures, and a network of early-stage backers, including XEIA Venture Partners, Jumpspace Ventures, Divergent Capital, SmartGateVC, Spacewalk VC, and several prominent angels, including Matt Krisiloff, Linhao Zhang, and Tim Shi.

This new funding will support the company’s first human trials, a critical milestone in developing a closed-loop, bi-directional cancer treatment system. The long-term vision: transform care for aggressive conditions like glioblastoma by shifting from reactive treatment to real-time monitoring and intervention.

Founded in 2022 by Cambridge researchers Ben Woodington and Elise Jenkins, Coherence Neuro is developing a new way to understand and treat disease by decoding the body’s electrical signals. Its flagship device, SOMA-1, monitors neural activity in real time and delivers targeted stimulation to help restore healthy function. As it collects continuous data, the platform becomes smarter with each use, building what the company calls the world’s largest disease-focused electrical data ecosystem to continually improve treatment over time.

Coherence Neuro starts from the belief that cancer represents a system-state disruption rather than an outside threat, and that restoring biological balance may offer a more precise alternative to conventional surgery, radiation, or chemotherapy. Instead of aggressive, episodic interventions, the company aims to make cancer treatment continuous and minimally invasive through data-driven neurostimulation, reframing cancer care as a process of real-time regulation rather than forceful eradication.